Rocket Pharma investors back 2026 meeting items
Rocket Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders, where holders of 80,774,659 common shares, representing approximately 74.02% of eligible shares, were present in person or by proxy.
Rhea-AI Filing Summary
Rocket Pharmaceuticals, Inc. held its 2026 Annual Meeting of Stockholders, where holders of 80,774,659 common shares, representing approximately 74.02% of eligible shares, were present in person or by proxy. Stockholders elected seven directors, with support generally above 59 million votes for each nominee.
They ratified EisnerAmper LLP as independent registered accounting firm for the fiscal year ending December 31, 2026, with 79,195,009 votes for and 1,002,656 against. Stockholders also approved, on a non-binding advisory basis, the compensation of the named executive officers and approved a stock option exchange program as described in the 2026 Proxy Statement.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares represented: 80,774,659 shares
Participation rate: 74.02%
Auditor ratification votes for: 79,195,009 votes
+3 more
6 metrics
Shares represented
80,774,659 shares
Present or by proxy at 2026 Annual Meeting
Participation rate
74.02%
Approximate share of total outstanding eligible to vote
Auditor ratification votes for
79,195,009 votes
EisnerAmper LLP for fiscal year ending December 31, 2026
Say-on-pay votes for
61,389,376 votes
Non-binding advisory vote on named executive officers’ compensation
Option exchange votes for
45,582,445 votes
Stock option exchange program approval
Broker non-votes
17,490,515 shares
On Proposals One, Three and Four
Key Terms
non-binding, advisory basis, independent registered accounting firm, broker non-votes, stock option exchange program
4 terms
non-binding, advisory basis financial
"stockholders approved, on a non-binding, advisory basis, the compensation of the Company’s named executive officers"
A non-binding, advisory basis means a recommendation or decision that carries no legal force and does not obligate the parties to act; it’s similar to a friendly suggestion rather than a signed promise. For investors, this matters because such guidance can influence market expectations and management plans but offers no guarantee of follow-through, so investors should treat it as informative input rather than a firm commitment.
independent registered accounting firm financial
"ratified the appointment of EisnerAmper LLP as the Company’s independent registered accounting firm"
An independent registered accounting firm is a third-party audit firm, usually a certified public accounting (CPA) practice, that is officially registered with the relevant regulator to perform audits of a public company's financial statements and controls. Like an impartial inspector checking a building's safety, it examines and certifies that a company’s financial records are accurate and comply with accounting rules, which helps investors trust the numbers reported by the company.
broker non-votes financial
"Votes For | | Votes Against | | Abstentions | | Broker Non-Votes 61,389,376 | | 1,671,016 | | 223,752 | | 17,490,515"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
stock option exchange program financial
"The Company’s stockholders approved the proposed stock option exchange program as described in the 2026 Proxy Statement."
FAQ
What quorum was reached at Rocket Pharmaceuticals (RCKT) 2026 annual meeting?
A quorum was achieved with 80,774,659 Rocket Pharmaceuticals shares represented, about 74.02% of outstanding shares eligible to vote. This level of participation allowed all four proposals on the agenda to be validly considered and voted upon at the 2026 Annual Meeting.
Which directors were elected at Rocket Pharmaceuticals (RCKT) 2026 annual meeting?
Seven directors were elected: Peter Fong, Carsten Boess, Mikael Dolsten, Fady Malik, Gaurav Shah, David P. Southwell, and Roderick Wong. Each received more votes for than withheld, with most nominees receiving over 59 million votes in favor, confirming their positions on the board.
Did Rocket Pharmaceuticals (RCKT) stockholders ratify the 2026 auditor?
Yes. Stockholders ratified EisnerAmper LLP as Rocket Pharmaceuticals’ independent registered accounting firm for the fiscal year ending December 31, 2026, with 79,195,009 votes for, 1,002,656 votes against, and 576,994 abstentions recorded in the auditor ratification proposal.
How did Rocket Pharmaceuticals (RCKT) stockholders vote on executive compensation?
Stockholders approved, on a non-binding advisory basis, the compensation of Rocket Pharmaceuticals’ named executive officers. The advisory vote received 61,389,376 votes for, 1,671,016 against, 223,752 abstentions, and 17,490,515 broker non-votes, reflecting overall support for the disclosed pay program.
Was Rocket Pharmaceuticals (RCKT) stock option exchange program approved?
Yes. Stockholders approved Rocket Pharmaceuticals’ stock option exchange program as described in the 2026 Proxy Statement. The proposal received 45,582,445 votes for, 17,615,213 votes against, 86,486 abstentions, and 17,490,515 broker non-votes, authorizing implementation of the exchange program by the company.
What were broker non-votes at Rocket Pharmaceuticals (RCKT) 2026 meeting?
Broker non-votes totaled 17,490,515 shares on the director elections, say-on-pay proposal, and stock option exchange program. These shares were counted for quorum purposes but were not voted on those specific proposals, consistent with standard broker voting rules and practices.
AI-generated analysis. How Rhea-AI works. Not financial advice.
